Andrew Cournoyer, RPh, MBA
Articles
New Reimbursement May Level Playing Field for Biosimilars
May 21st 2018The new Bipartisan Budget Act of 2018 (to be in effect on January 2019) institute new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.
Read More
Why New Reimbursement Guidelines for Biosimilars Could Increase Uptake
May 10th 2018The new Bipartisan Budget Act of 2018, to be in effect on January 2019, institutes new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.
Read More
Latest Updated Articles
Published: December 10th 2024 | Updated: December 22nd 2024
Next-Generation Testing Cheaper and More Effective for Guiding Lung Cancer Treatment
Published: July 20th 2020 | Updated: December 22nd 2024
For Better HCQ Retinopathy Guidelines, Include Prescribing Physicians
Published: October 3rd 2024 | Updated: December 22nd 2024
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
Published: October 7th 2024 | Updated: December 22nd 2024
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
Published: November 7th 2024 | Updated: December 22nd 2024
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
Published: July 11th 2024 | Updated: December 22nd 2024
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
